Czechia vs Finland: Death rate from cancer
Czechia
262.95 deaths per 100,000 people
in 2021
Finland
261.36 deaths per 100,000 people
in 2021
Czechia rank
23rd
Finland rank
24th
Death rate from cancer over time
- Czechia
- Finland
How they compare
Czechia currently reports 262.95 deaths per 100,000 people against 261.36 deaths per 100,000 people in Finland, a difference of 1.59 deaths per 100,000 people.
Across all 22 years both countries report, Czechia has been ahead every year.
Czechia ranks 23rd and Finland ranks 24th of 194 countries.
Czechia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 277.26 deaths per 100,000 people | 206.29 deaths per 100,000 people | 70.97 deaths per 100,000 people | Czechia |
| 2010s | 264.18 deaths per 100,000 people | 236.26 deaths per 100,000 people | 27.92 deaths per 100,000 people | Czechia |
| 2020s | 267.15 deaths per 100,000 people | 258.54 deaths per 100,000 people | 8.61 deaths per 100,000 people | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Czechia or Finland?
- Czechia, at 262.95 deaths per 100,000 people against 261.36 deaths per 100,000 people in Finland as of 2021.
- What is the difference in death rate from cancer between Czechia and Finland?
- 1.59 deaths per 100,000 people, with Czechia ahead.
- How many years of comparable data are there for Czechia and Finland?
- 22 years are reported by both, from 2000 to 2021.
- How do Czechia and Finland rank globally for death rate from cancer?
- Czechia ranks 23rd and Finland ranks 24th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.